RxDoctor Payments Data

Mark Melendez

Plastic and Reconstructive Surgery · Shelton, CTNPI 1982861860

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $43,538 of the $64,440 with a category attached, or 67.6%. Kerecis Limited accounts for 97.9% of it on its own, with 9 other manufacturers making up the rest. Among plastic and reconstructive surgery clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$64,440in general payments, 2019–2025

Across 64 payments — averaging $1006.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kerecis Limited$63K
  • Mentor Worldwide LLC$678
  • AbbVie$228
  • TELA Bio, Inc.$162
  • Sientra, Inc.$143
  • Organogenesis Inc.$60
  • plus $105 from 4 others

What the payments were for

  • Consulting fees$4,7007%
  • Speaking & faculty fees$43,53868%
  • Grants$3,3205%
  • Travel & lodging$7,20711%
  • Food & beverage$4,1766%
  • Education$1,5002%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$64,440 in reported general payments places this provider in the 95th percentile of 41 plastic and reconstructive surgery providers in Connecticut.

See all plastic and reconstructive surgery providers in Connecticut

Medicare billing

Part B allowed, 2024
$15,456
Medicare patients
43
Services billed
127

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other plastic and reconstructive surgery in Shelton

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →